Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

24 Jul 2014 07:00

RNS Number : 1641N
Halma PLC
24 July 2014
 



Halma plc

 

AGM/Interim Management Statement

 

24 July 2014

 

 

Halma, the leading safety, health and environmental technology group is holding its 120th AGM later today and makes the following Interim Management Statement relating to the period 30 March 2014 to date, with comments on trading relating to the first quarter ended 28 June 2014.

 

Market conditions have remained varied within our four sectors and the major geographic regions, while the increasing strength of sterling continues to provide a translation headwind. However, Halma has continued to achieve organic revenue growth at constant currency with order intake at 103% of revenue. This, together with the acquisitions completed in the first quarter, has positioned Halma to make further progress in the year ahead in line with the Board's expectations.

 

Process Safety performed well with growth from the USA, Mainland Europe, Middle East and South America offsetting lower revenue from Asia Pacific. The integration of RCS, the pipeline corrosion monitoring business acquired in May 2014, has started well and collaboration with Halma's other Process Safety companies is already underway.

 

The Infrastructure Safety sector made solid progress with encouraging growth in the UK and Mainland Europe. The integration into Halma of Advanced Electronics, the fire safety company acquired in May 2014, is also proceeding well.

 

Our Medical sector had a slow start to the year but is gaining momentum with good underlying growth in the USA and South America. Plasticspritzerei, acquired in May 2014, has been fully integrated into Medicel, the Halma company which manufactures devices for cataract surgery procedures.

 

The Environmental & Analysis sector delivered a mixed performance. Revenue growth in Mainland Europe and Asia Pacific has been encouraging although trading in the USA and UK has been more challenging. UK revenue has been affected by lower spending by water utilities which are now in the final year of their 5-year investment cycle.

 

As reported previously, since the start of the period we have completed three acquisitions and one disposal with a net cash cost of £78m. There have been no other material events or transactions during the period impacting upon the Group's financial position, which remains strong. We continue to identify potential acquisition opportunities which meet our strategic and financial criteria.

 

The half yearly results for the period ending 27 September 2014 are expected to be released on 18 November 2014.

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

 

 

NOTE TO EDITORS

 

1.

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises four business sectors:

 

● Process Safety

Products which protect assets and people at work.

 

● Infrastructure Safety

Products which detect hazards to protect assets and people in public spaces and commercial buildings.

 

● Medical

Products used to improve personal and public health.

 

● Environmental & Analysis

Products and technologies for analysis in safety, life sciences and environmental markets.

 

The key characteristics of Halma's businesses are that they are based on specialist technology and application knowledge, offering strong growth potential. Many Group businesses are market leaders in their specialist field.

 

2.

High resolution photos of Halma senior management, including Chief Executive Andrew Williams, and images illustrating Halma business activities can be downloaded from its website: www.halma.com. Click on the 'News & Media' link, then 'Image Library'. Photo queries: David Waller +44 (0)1494 721111, e-mail: dwaller@halmapr.com.

 

3.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma plc, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

4.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMGZNVFMGDZM
Date   Source Headline
1st Oct 20197:00 amRNSSite Visit
25th Sep 20197:00 amRNSTrading Statement
29th Jul 20199:44 amRNSDirector/PDMR Shareholding
25th Jul 20196:27 pmRNSResult of AGM
25th Jul 20197:00 amRNSNotice of Board Change
15th Jul 201911:01 amRNSHolding(s) in Company
15th Jul 201910:38 amRNSCompletion of Acquisition
4th Jul 20192:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:47 pmRNSDirector/PDMR Shareholding
2nd Jul 201910:34 amRNSHolding(s) in Company
21st Jun 201910:52 amRNSAnnual Financial Report
21st Jun 20197:00 amRNSAcquisition
11th Jun 20197:00 amRNSFinal Results
29th May 20194:00 pmRNSHolding(s) in Company
28th May 201912:59 pmRNSHolding(s) in Company
23rd May 201910:46 amRNSHolding(s) in Company
22nd May 20191:49 pmRNSHolding(s) in Company
21st May 20196:28 pmRNSHolding(s) in Company
17th May 20195:08 pmRNSHolding(s) in Company
13th May 201910:37 amRNSHolding(s) in Company
30th Apr 20199:33 amRNSHolding(s) in Company
17th Apr 201910:13 amRNSHolding(s) in Company
22nd Mar 20199:34 amRNSHolding(s) in Company
21st Mar 201912:30 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSTrading Statement
7th Feb 20192:00 pmRNSInvestor Event
18th Jan 20197:00 amRNSAcquisition
18th Dec 201811:02 amRNSDirector Declaration
20th Nov 20183:21 pmRNSDoc re. Half Year Report
20th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSAcquisition
19th Oct 20187:00 amRNSAcquisition
2nd Oct 20184:39 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSTrading Statement
2nd Aug 20183:29 pmRNSDirector/PDMR Shareholding
1st Aug 20185:23 pmRNSTotal Voting Rights
27th Jul 201810:39 amRNSDirector/PDMR Shareholding
19th Jul 20184:45 pmRNSResult of AGM
4th Jul 201810:25 amRNSDirector/PDMR Shareholding
26th Jun 20186:06 pmRNSDirector Declaration
19th Jun 20185:23 pmRNSAnnual Financial Report
12th Jun 20187:00 amRNSFinal Results
27th Mar 201810:02 amRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSTrading Statement
9th Feb 20183:49 pmRNSDirector/PDMR Shareholding
7th Feb 20182:00 pmRNSInvestor Event
16th Jan 20187:00 amRNSUS Tax Reform Update
21st Dec 20179:00 amRNSAcquisition
5th Dec 201710:10 amRNSDirector/PDMR Shareholding
21st Nov 20173:10 pmRNSDoc re. Half Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.